A detailed history of Jacobs Levy Equity Management, Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 367,514 shares of BCRX stock, worth $2.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
367,514
Previous 739,599 50.31%
Holding current value
$2.82 Million
Previous $4.57 Million 38.88%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.41 - $8.69 $2.39 Million - $3.23 Million
-372,085 Reduced 50.31%
367,514 $2.79 Million
Q2 2024

Aug 14, 2024

BUY
$4.13 - $6.79 $2.41 Million - $3.96 Million
583,480 Added 373.74%
739,599 $4.57 Million
Q1 2024

May 15, 2024

BUY
$4.89 - $7.65 $292,040 - $456,873
59,722 Added 61.95%
156,119 $793,000
Q4 2023

Feb 14, 2024

SELL
$4.98 - $6.77 $1.86 Million - $2.53 Million
-373,740 Reduced 79.5%
96,397 $577,000
Q3 2023

Nov 16, 2023

SELL
$6.71 - $7.92 $4.6 Million - $5.43 Million
-685,586 Reduced 59.32%
470,137 $3.33 Million
Q2 2023

Aug 14, 2023

SELL
$6.96 - $8.81 $6.12 Million - $7.74 Million
-878,620 Reduced 43.19%
1,155,723 $8.14 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $11.84 $4.5 Million - $6.7 Million
566,237 Added 38.57%
2,034,343 $17 Million
Q4 2022

Feb 14, 2023

BUY
$10.5 - $14.2 $11 Million - $14.9 Million
1,051,580 Added 252.46%
1,468,106 $16.9 Million
Q3 2022

Nov 15, 2022

BUY
$10.79 - $14.81 $4.49 Million - $6.17 Million
416,526 New
416,526 $5.25 Million
Q3 2020

Nov 16, 2020

SELL
$3.43 - $5.53 $258,495 - $416,757
-75,363 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$1.9 - $5.61 $108,799 - $321,245
57,263 Added 316.37%
75,363 $359,000
Q1 2020

May 15, 2020

SELL
$1.6 - $4.11 $3.36 Million - $8.62 Million
-2,098,317 Reduced 99.14%
18,100 $36,000
Q4 2019

Feb 14, 2020

BUY
$1.59 - $3.45 $776,924 - $1.69 Million
488,632 Added 30.02%
2,116,417 $7.3 Million
Q3 2019

Nov 14, 2019

BUY
$2.5 - $3.73 $4.07 Million - $6.07 Million
1,627,785 New
1,627,785 $4.66 Million

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.43B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.